These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 358782)

  • 1. Self-inhibitory dopamine receptors: their role in the biochemical and behavioral effects of low doses of apomorphine.
    Di Chiara G; Corsini GU; Mereu GP; Tissari A; Gessa GL
    Adv Biochem Psychopharmacol; 1978; 19():275-92. PubMed ID: 358782
    [No Abstract]   [Full Text] [Related]  

  • 2. Self-inhibitory dopamine-receptors and central effects of apomorphine.
    Di Chiara G; Porceddu ML; Morelli M; Gessa GL
    Ann Ist Super Sanita; 1978; 14(1):111-22. PubMed ID: 756166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apomorphine as a preferential stimulant of self-inhibitory dopamine receptors in man.
    Corsini GU; Del Zompo M; Piccardi MP; Mangoni A; Gessa GL
    Ann Ist Super Sanita; 1978; 14(1):123-30. PubMed ID: 756167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral effects of apomorphine during development of rats.
    Brus R; Herman ZS; Jamrozik Z
    Acta Physiol Pol; 1977; 28(3):243-6. PubMed ID: 561515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral, anti-dopaminergic, and prohypnotic effects of neuroleptics during and after prolonged treatment.
    Biazzi A; Fregnan GB
    Adv Biochem Psychopharmacol; 1980; 24():351-7. PubMed ID: 6105785
    [No Abstract]   [Full Text] [Related]  

  • 6. Kainic acid induced lesion of ventral tegmental area: locomotor effect of apomorphine.
    Morgenstern R
    Acta Biol Med Ger; 1980; 39(8-9):911-5. PubMed ID: 7282221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of castration on dopamine receptor sensitivity in male young rats: behavioral and neurophysiological studies.
    Asakura W; Ohta H; Matsumoto K; Imamura L; Watanabe H; Matsuda H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Apr; 14(2):77-82. PubMed ID: 8042347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Characteristics of "behavior modification" induced by dopaminergic stimulation].
    Costentin J; Baudry M; Marcais H; Martres MP; Protais P
    Arch Farmacol Toxicol; 1978 Apr; 4(1):64-5. PubMed ID: 29573
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of intracaudate administration of kainic acid on the activity of the dopaminergic system].
    Zharkovskiĭ AM; Nurk AM
    Fiziol Zh SSSR Im I M Sechenova; 1981 Nov; 67(11):1606-10. PubMed ID: 6799331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of striatal dopaminergic receptors in amphetamine-induced behavioral facilitation.
    Conway PG; Uretsky NJ
    J Pharmacol Exp Ther; 1982 Jun; 221(3):650-5. PubMed ID: 7201019
    [No Abstract]   [Full Text] [Related]  

  • 11. [Influence of the intracaudate administration of kainic acid on the effects of the prolonged use of haloperidol and apomorphine on rats].
    Zharkovskiĭ AM; Allikmets LKh; Nurk AM
    Farmakol Toksikol; 1982; 45(1):10-2. PubMed ID: 7198997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multisecond oscillations in the subthalamic nucleus: effects of apomorphine and dopamine cell lesion.
    Allers KA; Kreiss DS; Walters JR
    Synapse; 2000 Oct; 38(1):38-50. PubMed ID: 10941139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The locomotor and stereotype response to dopaminergic drugs and caffeine after intracerebroventricular kainic acid in rats.
    Kleinrok Z; Turski L; Wawrzyniak M; Cybulska R
    Pol J Pharmacol Pharm; 1981; 33(2):149-59. PubMed ID: 7198226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for dopamine receptors in the human brain mediating sedation and sleep.
    Corsini GU; Del Zompo M; Manconi S; Piccardi MP; Onali PL; Mangoni A
    Life Sci; 1977 May; 20(9):1613-8. PubMed ID: 875637
    [No Abstract]   [Full Text] [Related]  

  • 15. Circadian susceptibility rhythm to apomorphine in the brain.
    Nagayama H; Takagi A; Nakamura E; Yoshida H; Takahashi R
    Commun Psychopharmacol; 1978; 2(4):301-10. PubMed ID: 569566
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antagonism between L-DOPA and apomorphine in their effects on rat behavior].
    Allikmets LKh; Zharkovskiĭ Am; Vasar EE
    Biull Eksp Biol Med; 1977 Jul; 84(7):51-3. PubMed ID: 560890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apomorphine hypothermia: interaction with serotonergic agents.
    Kulkarni SK
    Pol J Pharmacol Pharm; 1980; 32(1):15-20. PubMed ID: 7192860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Demonstration of a new type of dopamine receptor agonist: an indolyl-3-butylamine. Actions at intact versus supersensitive dopamine receptors in the rat forebrain.
    Seyfried CA; Fuxe K; Wolf HP; Agnati LF
    Acta Physiol Scand; 1982 Dec; 116(4):465-8. PubMed ID: 7171006
    [No Abstract]   [Full Text] [Related]  

  • 20. Dopamine D-2 receptors in the ventral tegmental area mediate behavioural and electrocortical sleep of dopaminergic drugs in rats.
    Bagetta G; Priolo E; Nistico G
    Pharmacol Res Commun; 1988 Dec; 20(12):1091-2. PubMed ID: 2905475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.